PTX:ASX
Prescient Therapeutics Ltd
A$0.065
0.00%
(0.00) 1D
Oct 7, 4:00:00 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PTX...
Open
A$0.06
High
A$0.06
Low
A$0.06
Mkt. cap
67.82M
Avg. vol.
1.07M
Volume
536.71K
52-wk high
A$0.12
52-wk low
A$0.04
EPS
-A$0.01
Shares outstanding
1.14B
No. of employees
3
Open
A$0.06
High
A$0.06
Low
A$0.06
Mkt. cap
67.82M
Avg. vol.
1.07M
Volume
536.71K
52-wk high
A$0.12
52-wk low
A$0.04
EPS
-A$0.01
Shares outstanding
1.14B
No. of employees
3
News stories
From web sources and news partners
TipRanks
·
1 day ago
Prescient Director Increases Stake via Share Purchase Plan
TipRanks
·
1 day ago
Prescient Director Increases Indirect Stake via Share Purchase Plan
TipRanks
·
1 day ago
Prescient director boosts stake with additional share purchase
Profile
Prescient Therapeutics is a clinical-stage oncology company developing targeted therapies. Prescient's technologies emanate from prestigious world class centres including Yale, Penn, Oxford and Moffitt. Wikipedia
About Prescient Therapeutics Ltd
CEOSteven Yatomi-Clarke
Employees3
FoundedMay 22, 1986
Headquarters-
SectorBiotechnology
Websiteptxtherapeutics.com